Archer Investment Corporation’s Guardant Health GH Stock Holding History

Archer Investment Corporation’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-260	Closed	-$7.07K	–	869
2022 Q4	$7.07K	Hold	260	–	–	﹤0.01%	581
2022 Q3	$14K	Hold	260	–	–	0.01%	495
2022 Q2	$10.5K	Hold	260	–	–	﹤0.01%	526
2022 Q1	$18.3K	Sell	260 -3,800	-94%	-$260K	0.01%	487
2021 Q4	$406K	Sell	4,060 -500	-11%	-$51.7K	0.14%	163
2021 Q3	$570K	Hold	4,560	–	–	0.21%	114
2021 Q2	$566K	Buy	+4,560	New	+$613K	0.22%	100
2021 Q1	–	Sell	-5,235	Closed	-$675K	–	757
2020 Q4	$675K	Hold	5,235	–	–	0.32%	72
2020 Q3	$585K	Buy	+5,235	New	+$479K	0.3%	77
2020 Q2	–	Sell	-5,560	Closed	-$387K	–	654
2020 Q1	$387K	Buy	+5,560	New	+$427K	0.26%	94
2019 Q4	–	Sell	-4,100	Closed	-$262K	–	619
2019 Q3	$262K	Buy	4,100 +3,600	+720%	+$317K	0.16%	153
2019 Q2	$43K	Buy	+500	New	+$38.2K	0.03%	245

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Archer Investment Corporation's GH Position: Q1 2023 in Review

Archer Investment Corporation sold out of Guardant Health (GH) in Q1 2023, closing a stake of 260 shares — an estimated $7.07K sold.

Archer Investment Corporation first reported a position in GH in Q2 2019 and held it in 12 quarters. The position peaked at $675K in Q4 2020. 278 funds tracked by Wall St. Rank hold GH as of Q1 2023.

Archer Investment Corporation reported no remaining Guardant Health position as of Q1 2023 after selling out during the quarter.
Archer Investment Corporation sold 260 Guardant Health shares in Q1 2023, an estimated $7.07K.
Archer Investment Corporation first reported a position in Guardant Health in Q2 2019 and held it in 12 quarters.
Archer Investment Corporation's Guardant Health position peaked at $675K in Q4 2020.
278 funds tracked by Wall St. Rank held Guardant Health as of Q1 2023.

Based on Archer Investment Corporation's 13F filing for Q1 2023, filed 9 May 2023.